Jody Abrams, MD
Ophthalmology · Sarasota, FLNPI 1942229844
Payments from drug & device makers
Across 897 payments — averaging $574.33 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$439K
- Argenx US, Inc.$29K
- ANI Pharmaceuticals, Inc.$26K
- Osmotica Pharmaceutical Corp.$7K
- Bausch & Lomb, A Division Of Bausch Health US, LLC$6K
- AbbVie$2K
- plus $6K from 27 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen(2 entities) | 494 | $438,792 |
| Argenx US, Inc. | 55 | $28,553 |
| ANI Pharmaceuticals, Inc. | 50 | $26,458 |
| Osmotica Pharmaceutical Corp. | 5 | $7,425 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 5 | $6,374 |
| AbbVie(2 entities) | 83 | $1,794 |
| AstraZeneca | 42 | $1,538 |
| Biohaven Pharmaceuticals, Inc. | 21 | $649 |
| Bausch & Lomb Americas Inc. | 14 | $511 |
| Sun Pharmaceutical Industries Inc. | 12 | $438 |
| Pfizer | 44 | $405 |
| Biogen | 3 | $332 |
| Teva Pharmaceuticals USA, Inc. | 2 | $240 |
| Regeneron Healthcare Solutions, Inc. | 8 | $196 |
| UCB, Inc. | 6 | $152 |
| Sanofi | 2 | $138 |
| Genentech USA, Inc. | 5 | $134 |
| Merz Pharmaceuticals, LLC | 5 | $133 |
| Biohaven Pharmaceutical Holding Company Ltd. | 14 | $131 |
| Alcon | 2 | $120 |
| Novartis | 6 | $115 |
| Mallinckrodt Hospital Products Inc. | 1 | $98 |
| Shire North American Group Inc | 1 | $92 |
| Harrow Eye, LLC | 4 | $69 |
| Tarsus Pharmaceuticals, Inc. | 2 | $57 |
| Johnson & Johnson Surgical Vision, Inc. | 2 | $51 |
| Alimera Sciences, Inc. | 2 | $42 |
| Coherus Oncology, Inc. | 1 | $35 |
| Ocular Therapeutix, Inc. | 2 | $35 |
| Oyster Point Pharma, Inc. | 1 | $19 |
| Astellas Pharma US Inc | 1 | $17 |
| Notal Vision, Inc. | 1 | $17 |
| Smith+Nephew | 1 | $14 |
How this compares
$515,175 in reported general payments places this provider in the 95th percentile of 1,405 ophthalmology providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other ophthalmology in Sarasota
- Daniel KiernanSarasota$1.8M
- Robert SnyderSarasota$387K
- David EichenbaumSt Petersburg$34.4M
- Robert RadenDelray Beach$7.8M
- Carl DanzigPompano Beach$5.3M
- Bruce SegalDelray Beach$4.7M
- Cathleen McCabeBradenton$4.6M
- Ivan SunerTampa$3.7M
- Sunir JoshiFt Lauderdale$3.7M
- Harold BrooksTallahassee$3.5M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.